SCHEMBL366805

SCHEMBL366805

CC1(C)Cc2[nH]ncc2-c2nc(Nc3ncccn3)sc21.CC1Cc2[nH]ncc2-c2nc(Nc3ncccn3)sc21

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 20/20 0.51
KCNH2 Q12809 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL367276 0.90 GRM4 (0.61) GRM4KCNH2
SCHEMBL365817 0.89 GRM4 (0.62) GRM4KCNH2
SCHEMBL369235 0.79 GRM4 (0.48) GRM4KCNH2
SCHEMBL367148 0.78 GRM4 (0.65) GRM4KCNH2
SCHEMBL367422 0.78 GRM4 (0.64) GRM4KCNH2
SCHEMBL366576 0.78 GRM4 (0.61) GRM4KCNH2
SCHEMBL9995029 0.77 GRM4 (0.65) GRM4KCNH2
SCHEMBL370433 0.73 GRM4 (0.44) GRM4KCNH2
SCHEMBL367072 0.69 GRM4 (0.61) GRM4KCNH2
SCHEMBL360655 0.69 GRM4 (0.61) GRM4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593277-A2 NOVEL FUSED PYRAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX Pharma S.A. (CH) 2013-05-22 EP claimed
WO-2012009000-A2 NOVEL FUSED PYRAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO claimed
EP-2593277-A2 NOVEL FUSED PYRAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX Pharma S.A. (CH) 2013-05-22 EP disclosed
WO-2012009000-A2 NOVEL FUSED PYRAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO disclosed